Laserfiche WebLink
<br />. PERFORMING AGENCY'S FY 2001 Contract Renewal Application, and any <br />revisions; <br />. . Human Resources Code ~42.043, VTCA; <br />. Education Code ~~38.001-38.002, VTCA; <br />. Health and Safety Code ~~81.023 and 161.001-161.009, VTCA; <br />. 25 TAC ~~97.61-97.77 and 97.101-97.102; <br />. 25 TAC, Chapter 96; <br />. 25 TAC, Chapter 100; <br />. 42 USC ~~247b and 300 aa-25; <br />. Omnibus Budget Reconciliation Act of 1993, 26 USC ~4980B; <br />. RECEIVING AGENCY'S Client Services Standards for Public Health and <br />Community Clinics, revised June 1997; <br />. RECEIVING AGENCY'S Vaccine-Preventable Disease Surveillance guidelines, <br />March 15, 1999; <br />. RECEIVING AGENCY'S Pharmacy guidelines; <br />. Centers for Disease Control and Prevention's Advisory Committee on <br />Immunization Practices (ACIP) statement: "Immunization of Health-Care <br />Workers"; and <br />. Standards for Pediatric Immunization Practices, February 1996, recommended by <br />the National Vaccine Advisory Committee, approved by the United States Public <br />Health Service, and endorsed by the American Academy of Pediatrics. <br /> <br />Within thirty (30) days of receipt of an amended standard(s) or guideline(s), PERFORMING <br />AGENCY shall inform RECEIVING AGENCY Program, in writing, if it will not continue <br />performance under this Attachment in compliance with the amended standard(s) or guideline(s). <br />RECEIVING AGENCY may terminate the Attachment immediately or within a reasonable period <br />of time as determined by RECEIVING AGENCY. <br /> <br />PERFORMANCE MEASURES <br /> <br />The following performance measure(s) will be used, in part, to assess PERFORMING <br />AGENCY'S effectiveness in providing the services described in this contract Attachment to the <br />service area, without waiving the enforceability of any of the terms of the contract. <br /> <br />PERFORMING AGENCY shall investigate 100% of all reported vaccine-preventable <br />diseases in accordance with RECEIVING AGENCY'S Vaccine-Preventable Disease <br />Surveillance Guidelines. <br /> <br />PERFORMING AGENCY shall report 100% of all vaccine adverse event occurrences in <br />accordance with the National Vaccine Injury Act of 1986. <br /> <br />PERFORMING AGENCY shall investigate 100% of suspected hepatitis B infections in <br />pregnant women to assure appropriate treatment and follow-up as directed by Health and <br />Safety Code ~81.090 and RECEIVING AGENCY'S Vaccine-Preventable Disease <br />Surveillance Guidelines. <br /> <br />PERFORMING AGENCY shall provide an estimated.4..8Q8 doses of vaccine administered <br />to clients. <br /> <br />A TT ACHMENT - Page 3 <br />